Trending Feedback for Acute Respiratory Infection
Teladoc Health, Dallas, TX
Targeting 2 different conditionsTrending Feedback +3 moreN/AWaitlist AvailableLed by Daniella Meeker, PhDResearch Sponsored by University of Southern CaliforniaEligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Must not have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow ups12 months
Awards & highlights
No Placebo-Only Group
Study Summary
This trial will test if antibiotic prescribing can be reduced in a telehealth environment by using insights from decision and social psychology.
Eligible Conditions
- Acute Respiratory Infection
- Telemedicine
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow ups ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow ups ~ 12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in antibiotic prescribing rate for Acute Respiratory Infections
Secondary outcome measures
Change in inappropriate antibiotic prescribing rate for Acute Respiratory Infections
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
9Treatment groups
Experimental Treatment
Active Control
Group I: Trending Feedback + Public CommitmentExperimental Treatment2 Interventions
Clinicians receive both Trending Feedback + Public Commitment interventions.
Group II: Trending Feedback + Private CommitmentExperimental Treatment2 Interventions
Clinicians receive both Trending Feedback + Private Commitment interventions.
Group III: Trending Feedback + Commitment ControlExperimental Treatment1 Intervention
Clinicians receive Trending Feedback intervention + Commitment Control.
Group IV: Public Commitment + Feedback ControlExperimental Treatment1 Intervention
Clinicians receive Public Commitment intervention + Feedback Control.
Group V: Private Commitment + Feedback ControlExperimental Treatment1 Intervention
Clinicians receive Private Commitment intervention + Feedback Control.
Group VI: Benchmark Peer Comparison Feedback + Public CommitmentExperimental Treatment2 Interventions
Clinicians receive both Benchmark Peer Comparison Feedback + Public Commitment interventions.
Group VII: Benchmark Peer Comparison Feedback + Private CommitmentExperimental Treatment2 Interventions
Clinicians receive both Benchmark Peer Comparison Feedback + Private Commitment interventions.
Group VIII: Benchmark Peer Comparison Feedback + Commitment ControlExperimental Treatment1 Intervention
Clinicians receive Benchmark Peer Comparison Feedback intervention + Commitment Control.
Group IX: Commitment Control + Feedback ControlActive Control1 Intervention
Clinicians receive no intervention.
Find a site
Who is running the clinical trial?
University of Southern CaliforniaLead Sponsor
862 Previous Clinical Trials
1,468,324 Total Patients Enrolled
Agency for Healthcare Research and Quality (AHRQ)FED
383 Previous Clinical Trials
7,043,672 Total Patients Enrolled
Teladoc HealthIndustry Sponsor
1 Previous Clinical Trials
200 Total Patients Enrolled
Daniella Meeker, PhDPrincipal Investigator
University of Southern California3 Previous Clinical Trials
15,674,504 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is enrollment in the trial still available for those seeking treatment?
"The records on clinicaltrials.gov confirm that this trial, which was initially listed in March 2022 is not presently enrolling patients. Nonetheless, there are 93 other medical research studies open for recruitment at the moment."
Answered by AI
Recent research and studies